Xtandi (enzalutamide)

pCPA File Number: 21298
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Castration-Sensitive Prostate Cancer
Sponsor/Manufacturer:
Astellas Pharma Inc.
CDA-AMC Project Number:
PC0209-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: